OC051 Optogenetic control of localised β2-adrenoceptor (β2AR) signalling

被引：0
|
作者：
Mastos, Chantel [1 ]
机构：
[1] Monash Univ, Clayton, Vic, Australia
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 2023年 / 180卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
OC051
引用
收藏
页码：401 / 402
页数：2
相关论文
共 50 条
  • [1] Haplotype differences in agonist-induced desensitization of the lymphocyte β2-adrenoceptor (β2AR)
    Oostendorp, J.
    Postma, D. S.
    Volders, H.
    Jongepier, H.
    Kauffman, H. F.
    Bleecker, E. R.
    Nelemans, S. A.
    Zaagsma, J.
    Meurs, H.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2004, 18 : 37 - 37
  • [2] Agonist efficacy at the β2-adrenoceptor (β2AR) is driven agonist induced conformational differences that increase the affinity of the β2AR for the Gs protein and not ligand binding kinetics
    Harwood, Clare
    Briddon, Stephen
    Veprintsev, Dmitry
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 : 685 - 686
  • [3] β2-Adrenoceptor (β2AR) desensitization in tracheal smooth muscle cells induced by long-acting β2-sympathomimetics
    Teschemacher, A
    Lemoine, H
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R592 - R592
  • [4] β2-Adrenoceptor agonist profiling reveals biased signalling phenotypes for the β2-adrenoceptor with possible implications for the treatment of asthma
    De Pascali, Francesco
    Ippolito, Michael
    Wolfe, Emily
    Komolov, Konstantin E.
    Hopfinger, Nathan
    Lemenze, Douglas
    Kim, Nicholas
    Armen, Roger S.
    An, Steven S.
    Scott, Charles P.
    Benovic, Jeffrey L.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2022, 179 (19) : 4692 - 4708
  • [5] Beyond the dogma:: novel β2-adrenoceptor signalling in the airways
    Giembycz, M. A.
    Newton, R.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2006, 27 (06) : 1286 - 1306
  • [6] Evidence for a non-β2-adrenoceptor (β2AR) binding site in human lung tissue for the long acting β2-agonist (LABA) vilanterol
    Slack, Rob
    Barrett, Vikki
    Ford, Alison
    Knowles, Richard
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [7] Alterations in lymphocyte β2-adrenoceptor signalling in patients with left ventricular overload
    Dzimiri, N
    Moorji, A
    Basco, C
    Afrane, B
    Al-Halees, Z
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R597 - R597
  • [8] Biased 2-adrenoceptor signalling in heart failure: pathophysiology and drug discovery
    Woo, Anthony Yiu-Ho
    Song, Ying
    Xiao, Rui-Ping
    Zhu, Weizhong
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2015, 172 (23) : 5444 - 5456
  • [9] Chronic co-activation of the α2B- and β2-adrenoceptor (AR) facilitates desensitization of the α2B-AR
    Gokhale, AA
    Standifer, KM
    Eikenburg, DC
    [J]. FASEB JOURNAL, 2003, 17 (04): : A213 - A213
  • [10] β2-Adrenoceptor signalling bias in asthma and COPD and the potential impact on the comorbidities associated with these diseases
    Matera, Maria Gabriella
    Page, Clive
    Rinaldi, Barbara
    [J]. CURRENT OPINION IN PHARMACOLOGY, 2018, 40 : 142 - 146
12345